ABL1 and acute lymphoblastic leukemia: PEER and BE-13 cells are characterized by the NUP214-ABL1 fusion gene mutation, that is the most frequent and highly specific ABL1 fusion protein for T-lineage acute lymphoblastic leukemia, that transforms T-cells and is a constitutively active tyrosine kinase with oncogenic potential [23].